Impact of value-based care on quality of life, clinical outcomes, patient satisfaction, and enhanced financial protection among hypertensive patients in Ghana: A protocol for a mixed method evaluation, 2024

被引:0
作者
Dwomoh, Duah [1 ]
Sunkwa-Mills, Gifty [2 ]
Antwi, Kwasi Owusu [2 ]
Antwi, Maxwell Akwasi [2 ]
Rinke de Wit, Tobias Floris [3 ,4 ]
机构
[1] Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Accra, Ghana
[2] PharmAccess, Accra, Ghana
[3] PharmAccess, Amsterdam, Netherlands
[4] Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Amsterdam, Netherlands
来源
PLOS ONE | 2025年 / 20卷 / 04期
关键词
BURDEN; INTERVENTIONS; ASSOCIATION; DISEASE;
D O I
10.1371/journal.pone.0320861
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Evidence on which hypertensive intervention is cost-effective is essential to inform strategy, policy development, practice, implementation, and resource allocation. Value-Based Care (VBC) is a healthcare delivery model that emphasizes improving patient outcomes while optimizing costs. It shifts the focus from the volume of services provided to the value delivered to patients. We hypothesize that innovative VBC intervention would be more cost-effective compared to standard care among individuals with poorly controlled hypertension.Methods This study in Ghana will employ a mixed-methods evaluation design, a comprehensive and thorough approach that combines quantitative and qualitative methods. The quantitative component will involve a quasi-experimental study to measure the impact of the VBC intervention on quality of life, improved clinical outcomes, patient satisfaction, and enhanced financial protection among hypertensive patients registered with the National Health Insurance Authority. We will use a difference-in-difference analytic approach and a generalized estimation equation model with cluster-robust standard errors to quantify the impact of VBC, accounting for potential confounding variables. The qualitative component will involve in-depth interviews and focus group discussions to gather insights into the experiences and perceptions of the patients, caregivers, and policymakers involved in the VBC intervention and the benefits, barriers, costs of treatment, and challenges associated with the VBC intervention.Discussions Despite the availability of safe treatment options for hypertension, most people with hypertension in LMICs do not have it controlled. There is currently a paucity of knowledge about the cost-effectiveness of VBC interventions in developing countries. This study aims to fill this knowledge gap and pave the way for more cost-effective hypertension treatment worldwide. The Ghana VBC intervention described in this paper is a pioneering approach to achieving safer, more consistent, and cost-effective care for hypertensive patients.
引用
收藏
页数:17
相关论文
共 38 条
[1]  
Bigna JJ, Noubiap JJ., The rising burden of non-communicable diseases in sub-Saharan Africa, Lancet Glob Health, 7, 10, pp. e1295-e1296, (2019)
[2]  
Akpa OM, Made F, Ojo A, Ovbiagele B, Adu D, Motala AA, Et al., Regional patterns and association between obesity and hypertension in Africa: evidence from the H3Africa CHAIR Study, Hypertension, 75, 5, pp. 1167-1178, (2020)
[3]  
Schwalm J-D, McCready T, Lopez-Jaramillo P, Yusoff K, Attaran A, Lamelas P, Et al., A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial, Lancet, 394, 10205, pp. 1231-1242, (2019)
[4]  
Cappuccio FP, Miller MA., Cardiovascular disease and hypertension in sub-Saharan Africa: burden, risk and interventions, Intern Emerg Med, 11, 3, pp. 299-305, (2016)
[5]  
Nolla Sole JM., A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 380, 9859, pp. 2224-2260, (2012)
[6]  
Ferdinand KC., Uncontrolled hypertension in sub‐Saharan Africa: now is the time to address a looming crisis, J. Clin. Hypertens, 22, 11, (2020)
[7]  
A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013, (2013)
[8]  
Guwatudde D, Nankya-Mutyoba J, Kalyesubula R, Laurence C, Adebamowo C, Ajayi I, Et al., The burden of hypertension in sub-Saharan Africa: a four-country cross sectional study, BMC Public Health, 15, (2015)
[9]  
Bromfield S, Muntner P., High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs, Curr Hypertens Rep, 15, 3, pp. 134-136, (2013)
[10]  
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J., Global burden of hypertension: analysis of worldwide data, Lancet, 365, 9455, pp. 217-223, (2005)